This study is looking at men with prostate cancer who are being cared for with "Active Surveillance." This means instead of immediate treatment, your cancer is closely watched. The study wants to understand how well Active Surveillance works for men with low or very low-risk prostate cancer. You could be eligible if you are a man aged 18 or older with a recent diagnosis of prostate cancer that meets certain guidelines for Active Surveillance, including very low, low, or some intermediate-risk cases. The main goal is to estimate how many men on Active Surveillance will have their cancer progress over five years. This study is currently unclear on its recruitment status.

Study design

This is an observational study planning to enroll 100 participants. It is not testing a new treatment but rather observing how patients on Active Surveillance are managed.

What's involved

Participants will complete questionnaires, have physical and rectal exams, prostate biopsies, and imaging scans (like MRIs). These visits will happen between every 6 months and every 2-3 years, depending on the specific test or procedure.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint measures disease progression over an average of 1 year, through study completion.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.